Sign Up to like & get
recommendations!
0
Published in 2018 at "Hepatology"
DOI: 10.1002/hep.30366
Abstract: Sorafenib is the most recommended firstāline systemic therapy for advanced hepatocellular carcinoma (HCC). Yet there is no clinically applied biomarker for predicting sorafenib response. We have demonstrated that a vascular pattern, named VETC (Vessels that…
read more here.
Keywords:
benefit;
vetc;
sorafenib benefit;
tumor clusters ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Radiology"
DOI: 10.1148/radiol.2021203614
Abstract: Background Macrotrabecular-massive (MTM) subtype and vessels encapsulating tumor clusters (VETC) pattern of hepatocellular carcinoma (HCC) are associated with unfavorable prognosis. Purpose To estimate the potential of preoperative CT in the prediction of MTM subtype and…
read more here.
Keywords:
hepatocellular carcinoma;
subtype vessels;
tumor clusters;
subtype ... See more keywords